Advanced search
Publication Cover
Pharmacogenomics Volume 16, 2015 - Issue 10
Submit an article Journal homepage
6,913
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Comparative analysis between saliva and buccal swabs as source of DNA: lesson from HLA-B*57:01 testing

Raffaella Cascella1 Department of Biomedicine & Prevention, School of Medicine, University of Rome ‘Tor Vergata,’Rome, ItalyCorrespondence[email protected]
,
Laura Stocchi1 Department of Biomedicine & Prevention, School of Medicine, University of Rome ‘Tor Vergata,’Rome, Italy
,
Claudia Strafella1 Department of Biomedicine & Prevention, School of Medicine, University of Rome ‘Tor Vergata,’Rome, Italy
,
Ivano Mezzaroma2 Department of Clinical Medicine, ‘Sapienza’ University of Rome, Rome, Italy
,
Marco Mannazzu3 University of Sassari, Sassari, Italy
,
Vincenzo Vullo4 Department of Infectious Diseases, ‘Sapienza’ University of Rome, Rome, Italy
,
Francesco Montella5 Internal Medicine & Clinical Immunology Unit, ‘San Giovanni’ Hospital, Rome, Italy
,
Giustino Parruti6 Infectious Diseases Unit, Pescara General Hospital, Pescara, Italy
,
Paola Borgiani1 Department of Biomedicine & Prevention, School of Medicine, University of Rome ‘Tor Vergata,’Rome, Italy
,
Federica Sangiuolo1 Department of Biomedicine & Prevention, School of Medicine, University of Rome ‘Tor Vergata,’Rome, Italy
,
Giuseppe Novelli1 Department of Biomedicine & Prevention, School of Medicine, University of Rome ‘Tor Vergata,’Rome, Italy
,
Antonella Pirazzoli7 ViiV Healthcare, Verona, Italy
,
Stefania Zampatti8 Molecular Genetics Laboratory UILDM, Santa Lucia Foundation, Rome, Italy;9 Neuromed IRCCS, Pozzilli, Italy
&
Emiliano Giardina1 Department of Biomedicine & Prevention, School of Medicine, University of Rome ‘Tor Vergata,’Rome, Italy;8 Molecular Genetics Laboratory UILDM, Santa Lucia Foundation, Rome, Italy
 show all
Pages 1039-1046 | Published online: 31 Jul 2015

References

  • Hood L , FloresM . A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory . N. Biotechnol.29 ( 6 ), 613 – 624 ( 2012 ).
  • Hood L . Systems biology and p4 medicine: past, present, and future . Rambam Maimonides Med.4 ( 2 ), e0012 ( 2013 ).
  • Cohen JP . Overcoming regulatory and economic challenges facing pharmacogenomics . N. Biotechnol.29 ( 6 ), 751 – 756 ( 2012 ).
  • Ma Q , LuAY . Pharmacogenetics, pharmacogenomics, and individualized medicine . Pharmacol. Rev.63 ( 2 ), 437 – 459 ( 2011 ).
  • Phillips E , MallalS . Successful translation of pharmacogenetics into the clinic: the abacavir example . Mol. Diagn. Ther.13 ( 1 ), 1 – 9 ( 2009 ).
  • Hughes S , HughesA , BrothersC , SpreenW , ThorbornD . CNA106030 Study Team . PREDICT-1(CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events . Pharm. Stat.7 ( 2 ), 121 – 129 ( 2008 ).
  • Mallal S , PhillipsE , CarosiGet al. PREDICT-1 Study Team . HLA-B*5701 screening for hypersensitivity to abacavir . N. Engl. J. Med.358 ( 6 ), 568 – 579 ( 2008 ).
  • Saag M , BaluR , PhillipsEet al. Study of Hypersensitivity to Abacavir and Pharmacogenetic Evaluation Study Team . High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients . Clin. Infect. Dis.46 ( 7 ), 1111 – 1118 ( 2008 ).
  • Schackman BR , ScottCA , WalenskyRP , LosinaE , FreedbergKA , SaxPE . The cost–effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV . AIDS22 , 2025 – 2033 ( 2008 ).
  • Nieves Calatrava D , Calle-Martín OdeL , Iribarren-LoyarteJAet al. Cost–effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV+ patients in Spain . Enferm. Infec. Microbiol. Clin.28 ( 9 ), 590 – 595 ( 2010 ).
  • Kauf TL , FarkouhRA , EarnshawSR , WatsonME , MaroudasP , ChambersMG . Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV . Pharmacoeconomics28 ( 11 ), 1025 – 1039 ( 2010 ).
  • Stocchi L , CascellaR , ZampattiS , PirazzoliA , NovelliG , GiardinaE . The pharmacogenomic HLA biomarker associated to adverse abacavir reactions: comparative analysis of different genotyping methods . Curr. Genomics13 ( 4 ), 314 – 320 ( 2012 ).
  • WHO Guidance on Regulations for the Transport of Infectious Substances 2013–2014, WHO/HSE/GCR/12 (2012) .
  • Dianzani F , AntonelliG , CapobianchiMR , DoleiA . Prophylaxis and therapy of viral infections/human retrovirus . In : Manuale di Virologia Medica (Volume 10 and 18).McGraw-Hill , Italy . 117 – 119 / 233 – 253 ( 2008 ).
  • Cascella R , StrafellaC , RagazzoMet al. Direct PCR: a new pharmacogenetic approach for the inexpensive testing of HLA-B*57:01 . Pharmacogenomics J.1 – 5 ( 2014 ).
  • Martin AM , NolanD , MallalS . HLA-B*57.01 typing by sequence-specific amplification: validation and comparison with sequence-based typing . Tissue Antigens65 ( 6 ), 571 – 574 ( 2005 ).
  • Giardina E , StocchiL , CuzzolaVet al. A fluorescence-based sequence-specific primer PCR for the screening of HLA-B(*)57:01 . Electrophoresis21 , 3525 – 3530 ( 2010 ).
  • WHO . Antiretroviral medicines in low- and middle-income countries: forecasts of global and regional demand for 2012–2015 . AIDS Medicines and diagnostics service; HIV/AIDS Programme ( 2013 ).
  • Giardina E , PietrangeliI , MartoneCet al. Whole genome amplification and real-time PCR in forensic casework . BMC Genomics ( 10 ), 159 ( 2009 ).
  • Badulli C , SbarsiI , Di GiorgioDet al. A new approach to safely type for HLA the HIV infected people eligible to abacavir therapy: saliva or buccal swab as reliable DNA sources . Clin. Chim. Acta412 , 1995 – 1998 ( 2011 ).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.